TAMORX
TamoRx’s founding inventors have discovered a novel biological mechanism within cells that restricts the immune system from fighting cancer. The research team is focused on developing a new therapy that frees patients’ immune systems from this restriction to increase immune attack on cancer cells within tumours offering a new hope for a broad range of cancer patients. TamoRx aims to develop small molecule inhibitors that work both as a single agent and in combination with other treatments, increasing the applicability of immunotherapy for patients.
TAMORX
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2016-01-01
Address:
Auckland, Auckland, New Zealand
Country:
New Zealand
Status:
Active
Total Funding:
15.25 M NZD
Similar Organizations
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Group K Diagnostics
We put patient health 1st by revolutionizing rapid blood testing with a hand-held chemistry and ID analyzer for everyone, all in one.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Fore Biotherapeutics
We are a precision oncology company pioneering the development of cancer therapies guided by our proprietary functional genomics.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Investors List
Brandon Capital
Brandon Capital investment in Venture Round - TamoRx
University of Auckland Inventors Fund
University of Auckland Inventors Fund investment in Venture Round - TamoRx
More informations about "TamoRx"
TamoRx - Brandon Capital
TamoRx’s founding inventors have discovered a novel biological mechanism within cells that restricts the immune system from fighting cancer. The research team is focused on developing …See details»
TamoRx 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for TamoRx. Use the PitchBook Platform to explore the full profile.See details»
Uni biotech spin-off developing cancer treatment gets …
May 31, 2022 TamoRx, a biotech start-up spun out of the University of Auckland, is getting $15.25m to accelerate the development of a treatment for cancer. Founded by Dr Joanna Mathy and Professor Rod Dunbar from the …See details»
TamoRx - Crunchbase Company Profile & Funding
TamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.See details»
MWC investigators found new cancer therapy start-up …
News // MWC investigators found new cancer therapy start-up TAMORx 3 June 2022 MWC investigators Dr Joanna Mathy and Prof Rod Dunbar lead new cancer therapy drug research company, TAMORx, based upon MWC supported …See details»
Kiwi cancer start-up receives $15m to develop new …
May 25, 2022 The company, TamoRx, was founded by the University of Auckland's Dr Joanna Mathy and Professor Rod Dunbar. Led by Mathy, TamoRx will focus on improving the immune attack on cancer cells within tumours. "We …See details»
TamoRx Ltd - Company Profile and News - Bloomberg Markets
Company profile page for TamoRx Ltd including stock price, company news, executives, board members, and contact informationSee details»
Brandon Capital: Giving life science startups a place to …
Oct 3, 2024 The global venture capital firm has raised over $1 billion so far through six funds, investing in local innovations TamoRx and Amaroq Therapeutics, two companies targeting novel cancer treatments which have …See details»
TAMORX LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TAMORX LIMITED of Auckland, AUCKLAND. Get the latest business insights from Dun & Bradstreet.See details»
Announcements, Bif Acquires Shares In Tamorx - NZX
Dec 23, 2022 BIF acquires shares in TamoRx 23/12/2022, 13:29 NZDT, TRANSACT Booster is pleased to announce the addition of TamoRx, to the Booster Innovation Fund (BIF) portfolio. …See details»
Over $15m invested in world-leading cancer immunotherapy
Jun 6, 2022 University of Auckland spinout targeting new cancer treatment TamoRx, a biotech start-up recently spun out of the University of Auckland, has received NZ$15.25m investment …See details»
Brandon Capital backs New Zealand immunotherapy start-up
May 25, 2022 Brandon Capital has partnered with another investor to inject NZ$15.25 million into the University of Auckland spin-out TamoRx. The company, founded by Dr Joanna Mathy …See details»
Over $15m invested in AK University biotech startup
May 25, 2022 Biotech startup TamoRx has received $15.25 million in investment to speed up development of a new cancer treatment. The startup, spun out recently from the University of …See details»
TamoRx - Funding, Financials, Valuation & Investors - Crunchbase
TamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.See details»
Venture Round - TamoRx - 2022-06-06 - Crunchbase Funding …
Overview Edit Overview Section Organization Name TamoRx Announced DateJun 6, 2022 Funding TypeVenture - Series Unknown Money Raised obfuscated obfuscatedSee details»
Tamarix Pharma - 2025 Company Profile - Tracxn
May 22, 2025 Tamarix Pharma is a funded company based in Jerusalem (Israel), founded in 2021. It operates as a Developer of small molecule therapeutics to reduce apoptosis-related …See details»
Tamarix Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Tamarix Pharma. Use the PitchBook Platform to explore the full profile.See details»
Brandon Capital backs New Zealand immunotherapy start-up
May 26, 2022 Australian company Brandon Capital has partnered with another investor to inject NZ$15.25 million into the University of Auckland spin-out TamoRx. The company, founded by …See details»
TamoRx - Updates, News, Events, Signals & Triggers - Crunchbase
TamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.See details»
TamoRx - Crunchbase
TamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.See details»